PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 2026Life1 citationsOpen Access

Applications of Nanobiotechnology in Medicine

EKEwa KaznowskaKDKlaudia DynarowiczRzeszów UniversityIRIzabela RudyScience Club

Key Points

  • The aim is to explore how nanobiotechnology can address complex clinical issues through molecular interactions.
  • Defined nanobiotechnology and its application in clinical settings.
  • Discussed various nanostructures like nanoparticles and their properties.
  • Outlined applications in drug delivery, diagnostics, and tissue engineering.
  • Improved drug bioavailability and minimized side effects were noted.
  • Higher sensitivity in early disease detection was achieved with nanosystems.
  • Potential for personalized treatment strategies was highlighted.

Abstract

Nanobiotechnology, defined as the application of nanotechnology in biology and medicine, refers to the use of nanometric structures to solve complex clinical problems through precise interaction at the molecular level. Nanostructures such as lipid, polymer, and metallic nanoparticles offer unique properties that enable improved therapeutic and diagnostic efficacy and the integration of diagnostic and therapeutic functions within the concept of theranostics. Major applications of nanobiotechnology include targeted drug delivery in cancer, infection, and gene therapy; advanced molecular diagnostics and biosensors; tissue engineering and regeneration; and immune system modulation through modern nanotechnology-based vaccines and immunotherapies. The clinical significance of these technologies lies in their ability to improve drug bioavailability, minimize adverse effects, increase sensitivity in early disease detection, and support personalized treatment strategies. Nanobiotechnology also contributes to the development of precision medicine by combining diagnostics and therapy within a single nanosystem. Despite promising results, significant challenges remain related to safety, biocompatibility, toxicity, and translation from laboratory studies to clinical applications. Further research is needed to standardize methods, assess the long-term health impact of nanomaterials, and develop regulatory frameworks to fully realize the potential of nanobiotechnology in medicine.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kaznowska et al. (2026) studied this question.

synapsesocial.com/papers/698d6e2a5be6419ac0d53a40https://doi.org/10.3390/life16020302
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanobiosensors for Single-Molecule Diagnostics: Toward Integration with Super-Resolution Imaging2025 · 10 citations
  2. 2Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives2024 · 76 citations
  3. 3Controlled drug release from pharmaceutical nanocarriers2014 · 623 citations
  4. 4Nanotechnologies in regenerative medicine2010 · 102 citations
  5. 5Nanomaterial-based contrast agents2023 · 129 citations